Jazz begins shipping anxiety/OCD drug Luvox

PALO ALTO, Calif. Jazz Pharmaceuticals recently began shipping its new drug, once daily Luvox CR extended-release capsules to pharmacies across the country. The drug is designed to treat social anxiety disorder and obsessive-compulsive disorder in adults.

The drug is available in 100 mg and 150 mg strengths.

“We are very excited about the introduction of Luvox CR to the United States market. The availability of Luvox CR provides physicians with a new and effective treatment option for the millions of adults in the United States suffering from SAD and OCD,” said Samuel Saks, chief executive officer of Jazz Pharmaceuticals. “Through our educational efforts, we hope to provide physicians and their patients with important information about SAD and OCD. As part of our commitment to helping patients, their families and caregivers, we are working with advocacy organizations to increase awareness about these serious and underdiagnosed conditions.”